Business
from24/7 Wall St.
16 hours agoIs the Pepsico Turnaround Story Finally Worth Buying?
PepsiCo faced volume declines but achieved revenue growth through pricing, while net income fell due to impairment charges.
Credit cards can be very dangerous from a financial well-being perspective, if used irresponsibly. The temptation to use one to fund a big holiday or a new sofa that you can't afford can be seriously tempting.
Citi's concern is mainstream DDR5 16GB DRAM prices have fallen 6% since Micron's earnings report, driven by fears that TurboQuant, an algorithm-based memory compression technology, will structurally reduce memory demand. Citi isn't buying it.
MORT holds shares in mortgage real estate investment trusts, companies that borrow at short-term rates and invest in mortgage-backed securities or originate real estate loans. The income MORT distributes comes from the dividends paid by the underlying mREITs to their shareholders.
The fund blends high yield corporate bonds, senior loans, and debt tranches of U.S. collateralized loan obligations (CLOs) into a single actively managed portfolio, aiming to deliver income that beats the broad bond market while keeping volatility lower than any single segment on its own.
HYBL attempts to solve the income problem by combining senior loans, high-yield corporate bonds, and debt tranches from U.S. collateralized loan obligations (CLOs). The result is a portfolio with lower duration and lower volatility compared to traditional high-yield funds, while still targeting high current income with monthly distributions.
Markup is how much you add to your cost to get your selling price. If something costs $10 and you sell it for $15 , you added $5. That's a 50 percent markup on your cost. Where people get confused is that markup isn't the same as margin, even though the terms get used interchangeably all the time. Margin measures profit as a percentage of the selling price, and markup measures it based on your costs. Same dollar, different percentages.
The ETF holds 50 positions, but the top two dominate in a way that makes the rest almost incidental. Johnson & Johnson carries a 25.4% weight, and Eli Lilly and Company sits at 21.4%. Together they account for roughly 46.8% of the entire fund.
The emergence of so-called "agentic AI," systems that can perform tasks independently and support decisions, plays a central role in this. Two-thirds of respondents believe that there is currently more hype surrounding agentic AI than previous technological developments. At the same time, three-quarters are still discovering how this technology can be used effectively. According to Basware CEO Jason Kurtz, the time for experimentation is over; executives expect concrete results.